Skip to content
MedsAcross

Medicine

Ascomp with Codeine 325 mg/50 mg/40 mg/30 mg capsule

Aspirin, Butalbital, Caffeine and Codeine · Oral · LGM Pharma Solutions
Available on requestPrescription onlyUS FDAControlled, schedule CIII

Ascomp with Codeine 325 mg/50 mg/40 mg/30 mg capsule is a prescription medicine containing Aspirin, Butalbital, Caffeine and Codeine for oral use, marketed by LGM Pharma Solutions, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store and Dispense Store below 25°C (77°F) in a tight, light-resistant…

Key facts

Active ingredient (INN)
Aspirin, Butalbital, Caffeine and Codeine
Brand
Ascomp with Codeine
Strength
325 mg/50 mg/40 mg/30 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 500 capsules
Marketing authorisation holder
LGM Pharma Solutions
Manufacturers
LGM Pharma SolutionsBreckenridge Pharmaceutical
Origin register
US FDA, United States
Storage
Store and Dispense Store below 25°C (77°F) in a tight, light-resistant container. Protect from moisture. Store ASCOMP with Codeine securely and dispose of properly.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIII
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
30 November 2001
Identifiers
RxCUI 994237, 994239DailyMed set ID 243a6aea-0f48-42a9-a85e-ff247ab94336, 1cab3106-1064-4b42-892b-39f405d9e02fNDC 51991-074, 79739-6094Application ANDA075231

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
100 capsule in 1 bottle79739-6094-1LGM Pharma Solutions24 July 2020
100 capsule in 1 bottle, plastic51991-074-01Breckenridge Pharmaceutical1 May 2009
500 capsule in 1 bottle, plastic51991-074-05Breckenridge Pharmaceutical1 May 2009

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 26 October 1990Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Aspirin, Butalbital, Caffeine and Codeine 325 mg/50 mg/40 mg/30 mg capsule.

Compare 1

Clinical summary

Aspirin, Butalbital, Caffeine and Codeine is a fixed-dose combination of a barbiturate, a central nervous system stimulant and a methylxanthine. It is available as capsules for oral use. MedsAcross supplies Aspirin, Butalbital, Caffeine and Codeine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Aspirin, Butalbital, Caffeine and Codeine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ascomp with Codeine 325 mg/50 mg/40 mg/30 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.